Synthesis, cytotoxic activity evaluation and mechanistic investigation of novel 3,7-diarylsubstituted 6-azaindoles

  • Eur J Med Chem. 2023 Sep 13:261:115804. doi: 10.1016/j.ejmech.2023.115804.
Nikolaos Lougiakis  1 Nikolaos Sakalis  2 Maria Georgiou  2 Panagiotis Marakos  2 Nicole Pouli  2 Alexios-Leandros Skaltsounis  3 Eleni Mavrogonatou  4 Harris Pratsinis  4 Dimitris Kletsas  4
Affiliations
  • 1. Division of Pharmaceutical Chemistry, Department of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, Panepistimiopolis Zografou, 15771, Athens, Greece. Electronic address: [email protected].
  • 2. Division of Pharmaceutical Chemistry, Department of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, Panepistimiopolis Zografou, 15771, Athens, Greece.
  • 3. Division of Pharmacognosy and Natural Products Chemistry, Department of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, Panepistimiopolis Zografou, 15771, Athens, Greece.
  • 4. Laboratory of Cell Proliferation and Ageing, Institute of Biosciences and Applications, NCSR ''Demokritos'', 15310, Athens, Greece.
Abstract

A number of new disubstituted 6-azaindoles have been designed and synthesized bearing a crucial structural modification in respect to an analogous antiproliferative hit compound. The synthesis was performed using 2-amino-3-nitro-4-picoline, that was suitably modified and converted to 7-chloro-3-iodo-6-azaindole and this central scaffold was used for successive Suzuki-type couplings, to result in the target compounds. The evaluation of the cytotoxic activity was performed against four human Cancer cell lines, as well as a normal human fibroblast strain. Certain compounds possessed strong Anticancer activity without affecting normal cells. At subcytotoxic concentrations for Cancer cells, these compounds displayed an anti-proliferative effect by arresting the cells at the G2/M phase of the cell cycle, which could be associated with the observed decrease in the phosphorylation levels of the MEK1- ERK1/2 pathway and/or the activation of the p53-p21WAF1 axis.

Keywords
Antiproliferative; Cell cycle arrest; Purine; Pyrrolopyridine; Selectivity; Suzuki-type coupling.
Products